Stocks and Investing
Stocks and Investing
Tue, April 7, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Suraj Kalia Initiated (ATRC) at Buy and Held Target at $45 on, Apr 7th, 2020
Suraj Kalia of Oppenheimer, Initiated "AtriCure, Inc." (ATRC) at Buy and Held Target at $45 on, Apr 7th, 2020.
Suraj has made no other calls on ATRC in the last 4 months.
There are 2 other peers that have a rating on ATRC. Out of the 2 peers that are also analyzing ATRC, 0 agree with Suraj's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Suraj
- Mike Matson of "Needham" Maintained at Strong Buy with Increased Target to $52 on, Wednesday, February 19th, 2020
- Sean Lavin of "BTIG" Maintained at Strong Buy with Increased Target to $48 on, Wednesday, February 19th, 2020